Primary Site >> Liver Cancer
Gene >> SLC16A4
|
|
|
|
|---|---|---|---|
|
Ref: Metabolic signature genes associated with susceptibility to pyruvate kinase, muscle type 2 gene ablation in cancer cells. PMID: 23515579 |
Ref: Characterization of monocarboxylate transporter activity in hepatocellular carcinoma. PMID: 25206282 |
Ref: Preclinical Benefit of Hypoxia-Activated Intra-arterial Therapy with Evofosfamide in Liver Cancer. PMID: 27440271 |
Ref: Aberrant MCT4 and GLUT1 expression is correlated with early recurrence and poor prognosis of hepatocellular carcinoma after hepatectomy. PMID: 30306706 |